Advertisement
"One reason for this shift is the Deficit Reduction Act that came intoeffect in January 2007, in which reimbursement for a variety of proceduresperformed by IRs was cut," says Kevin Flewwelling, Senior Analyst at MRG. "Asa result, IRs may be looking to perform more favorably reimbursed proceduressuch as kyphoplasty. With IRs putting more effort into becoming trained onthis treatment, Marketrack data shows that the number of procedures theyperform is growing."
Advertisement
In the first quarter of 2007, of the facilities performing minimallyinvasive VCF treatments, the average number of kyphoplasty proceduresperformed in an IR facility was just over 9. In the second quarter of 2007,this number rose to nearly 12. As a result, IR facilities accounted for nearly47% of total kyphoplasty volumes captured by the survey sample in the firstsix months of 2007.
About Vertebral Compression Fracture Treatments
Kyphoplasty and vertebroplasty are minimally invasive, nonsurgicalprocedures designed to relieve the pain caused by VCFs. Both proceduresinvolve the insertion of a special bone needle through the posterior softtissues and the injection of a small amount of orthopedic cement through theneedle into the vertebral body. Additionally, kyphoplasty involves twoproprietary balloon devices that are inserted into the vertebral body andgradually inflated, thereby restoring it to its prefracture shape and height.
About Vertebral Compression Fracture Treatment Marketrack
VCF Treatment Marketrack gathers quarterly data from interventionalradiology suites and spine facilities throughout the US. Marketracksubscribers receive thousands of data points, including usage (units, averageselling price, and revenue), procedure, competitor, and brand information.
About Millennium Research Group
Millennium Research Group (www.MRG.net), a Decision Resources, Inc.company (www.DecisionResources.com), is the global authority on medicaltechnology market intelligence and a leading provider of strategic informationto the health care sector. Focused solely on the medical device,pharmaceutical, and biotechnology industries, the company provides its clientswith the benefits of its specialized industry expertise through publishedreports and customized consulting services.
All company, brand, or product names contained in this document may betrademarks or registered trademarks of their respective holders.For more information, contact: Amy Krohn Millennium Research Group 416-364-7776 x101 [email protected]
SOURCE Millennium Research Group
